Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TRANSFERRIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | TRANSFERRIN |
| Chromosome | 3q21. |
| Molecular Weight | 80 kDa |
| Amino Acids | 679 aa |
| Pathways | Blood-Brain Barrier, Oxidative Stress, Autophagy, Mitophagy, Mitochondrial Function |
| GeneCards | TRANSFERRIN |
| Human Protein Atlas | TRANSFERRIN |
| Associated Diseases | cancer, ferroptosis, ISCHEMIA |
| Interactions | FERROPORTIN, GPX4, HEPCIDIN, IGF2R, Proteins, SLC7A11 |
| KG Connections | 37 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TRANSFERRIN["TRANSFERRIN"]
IRON_METABOLISM["IRON METABOLISM"]
TRANSFERRIN -->|"involved in"| IRON_METABOLISM
TFR1["TFR1"]
TRANSFERRIN -->|"binds"| TFR1
TFR1["TFR1"]
TFR1 -->|"binds"| TRANSFERRIN
TRANSFERRIN_RECEPTOR_1["TRANSFERRIN RECEPTOR 1"]
TRANSFERRIN_RECEPTOR_1 -->|"binds to"| TRANSFERRIN
TRANSFERRIN_RECEPTOR_2["TRANSFERRIN RECEPTOR 2"]
TRANSFERRIN_RECEPTOR_2 -->|"binds to"| TRANSFERRIN
TFR2["TFR2"]
TFR2 -->|"binds"| TRANSFERRIN
TXB2["TXB2"]
TXB2 -->|"associated with"| TRANSFERRIN
ISCHEMIA["ISCHEMIA"]
TRANSFERRIN -->|"associated with"| ISCHEMIA
FERROPORTIN["FERROPORTIN"]
TRANSFERRIN -->|"associated with"| FERROPORTIN
MACROPHAGES["MACROPHAGES"]
TRANSFERRIN -->|"associated with"| MACROPHAGES
HEPATOCYTES["HEPATOCYTES"]
TRANSFERRIN -->|"associated with"| HEPATOCYTES
ferroptosis["ferroptosis"]
TRANSFERRIN -->|"associated with"| ferroptosis
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
TRANSFERRIN -->|"activates"| BLOOD_BRAIN_BARRIER
Proteins["Proteins"]
TRANSFERRIN -->|"activates"| Proteins
Proteins["Proteins"]
TRANSFERRIN -->|"regulates"| Proteins
Genes["Genes"]
TRANSFERRIN -->|"interacts with"| Genes
ST6GAL1["ST6GAL1"]
TRANSFERRIN -->|"interacts with"| ST6GAL1
FUT8["FUT8"]
TRANSFERRIN -->|"interacts with"| FUT8
IGF2R["IGF2R"]
TRANSFERRIN -->|"interacts with"| IGF2R
SORTILIN["SORTILIN"]
TRANSFERRIN -->|"interacts with"| SORTILIN
INSULIN["INSULIN"]
TRANSFERRIN -->|"interacts with"| INSULIN
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
TRANSFERRIN -->|"associated with"| BLOOD_BRAIN_BARRIER
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
TRANSFERRIN -->|"interacts with"| BLOOD_BRAIN_BARRIER
cancer["cancer"]
TRANSFERRIN -->|"associated with"| cancer
FERROPORTIN["FERROPORTIN"]
TRANSFERRIN -->|"interacts with"| FERROPORTIN
HEPCIDIN["HEPCIDIN"]
TRANSFERRIN -->|"interacts with"| HEPCIDIN
ferroptosis["ferroptosis"]
TRANSFERRIN -->|"activates"| ferroptosis
GLUTAMATE["GLUTAMATE"]
TRANSFERRIN -->|"activates"| GLUTAMATE
CATALASE["CATALASE"]
TRANSFERRIN -->|"associated with"| CATALASE
FERROPORTIN["FERROPORTIN"]
TRANSFERRIN -->|"regulates"| FERROPORTIN| Target | Relation | Type | Str |
|---|---|---|---|
| IRON METABOLISM | involved_in | entity | 0.95 |
| Glycosylation | involved_in | process | 0.95 |
| Iron | binds | compound | 0.90 |
| Tfr1 | binds | receptor | 0.90 |
| Iron | delivers | chemical | 0.90 |
| NEURON | transports | cell_type | 0.90 |
| Transferrin Receptor 1 | activates | protein | 0.80 |
| hepatocytes | binds | cell | 0.80 |
| IgG | co_expressed_with | protein | 0.75 |
| Ischemia | causes | disease | 0.60 |
| Ischemia | associated_with | disease | 0.60 |
| Als | regulates | disease | 0.60 |
| Cancer | regulates | disease | 0.60 |
| Ferroptosis | biomarker_for | disease | 0.60 |
| Lymphoma | biomarker_for | disease | 0.60 |
| Cancer | biomarker_for | disease | 0.60 |
| Als | biomarker_for | disease | 0.60 |
| Aging | therapeutic_target | disease | 0.60 |
| Alzheimer | therapeutic_target | disease | 0.60 |
| Als | therapeutic_target | disease | 0.60 |
| Dementia | causes | disease | 0.60 |
| Alzheimer | causes | disease | 0.60 |
| Ferroptosis | causes | disease | 0.60 |
| Als | causes | disease | 0.60 |
| Parkinson | interacts_with | disease | 0.60 |
| Cancer | therapeutic_target | disease | 0.60 |
| Alzheimer | expressed_in | disease | 0.60 |
| Fibrosis | activates | disease | 0.60 |
| Diabetes | inhibits | disease | 0.60 |
| Ferroptosis | inhibits | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| Mitochondrial Function | activates | pathway | 0.55 |
| Oxidative Stress | activates | pathway | 0.55 |
| Autophagy | activates | pathway | 0.55 |
| Mitophagy | activates | pathway | 0.55 |
| Blood-Brain Barrier | activates | pathway | 0.55 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.55 |
| Oxidative Stress | biomarker_for | pathway | 0.55 |
| Blood-Brain Barrier | associated_with | pathway | 0.55 |
| Proteins | regulates | protein | 0.50 |
| ST6GAL1 | interacts_with | concept | 0.50 |
| FUT8 | interacts_with | concept | 0.50 |
| IGF2R | interacts_with | protein | 0.50 |
| SORTILIN | interacts_with | protein | 0.50 |
| INSULIN | interacts_with | concept | 0.50 |
| cancer | associated_with | disease | 0.50 |
| FERROPORTIN | interacts_with | protein | 0.50 |
| HEPCIDIN | interacts_with | protein | 0.50 |
| ferroptosis | activates | phenotype | 0.50 |
| GLUTAMATE | activates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TRANSFERRIN RECEPTOR 1 | binds_to | entity | 0.95 |
| TRANSFERRIN RECEPTOR 2 | binds_to | entity | 0.90 |
| Transferrin Receptor 1 | binds | receptor | 0.90 |
| Transferrin Receptor 2 | binds | protein | 0.90 |
| TXB2 | associated_with | compound | 0.85 |
| TXB2 | associated_with | drug | 0.75 |
| JUN | regulates | gene | 0.60 |
| FERROPORTIN | transports | gene | 0.60 |
| DMT1 | transports | gene | 0.60 |
| TFR1 | transports | gene | 0.60 |
| TFR1 | activates | gene | 0.60 |
| TAU | therapeutic_target | gene | 0.60 |
| GPX4 | causes | gene | 0.60 |
| TAU | causes | gene | 0.60 |
| FUT8 | associated_with | gene | 0.60 |
| ST6GAL1 | associated_with | gene | 0.60 |
| IGF2R | therapeutic_target | gene | 0.60 |
| GBA1 | interacts_with | gene | 0.60 |
| TFRC | interacts_with | gene | 0.60 |
| HFE | regulates | gene | 0.60 |
| TFR1 | interacts_with | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| GPX4 | inhibits | gene | 0.60 |
| VDR | inhibits | gene | 0.60 |
| SLC7A11 | inhibits | gene | 0.60 |
| MAP2 | regulates | gene | 0.60 |
| APOE | regulates | gene | 0.60 |
| GPX4 | regulates | gene | 0.60 |
| FERROPORTIN | regulates | gene | 0.60 |
| FERROPTOSIS | inhibits | gene | 0.60 |
| GSH | inhibits | gene | 0.60 |
| TFR1 | associated_with | gene | 0.60 |
| JUN | interacts_with | gene | 0.60 |
| TFR1 | regulates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| FERROPTOSIS | biomarker_for | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| AMYLOID-BETA | therapeutic_target | gene | 0.60 |
| ALZHEIMER | causes | gene | 0.60 |
| DEMENTIA | causes | gene | 0.60 |
| FERROPTOSIS | causes | gene | 0.60 |
| MICROGLIA | therapeutic_target | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| ASTROCYTES | therapeutic_target | gene | 0.60 |
| MALAT1 | therapeutic_target | gene | 0.60 |
| PARKINSON | interacts_with | gene | 0.60 |
| RNA | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| pH-Sensitive Bispecific Antibody Targeting Transferrin Recep | 0.800 | neurodegeneration | Blood-brain barrier antibody transport m |
| Magnetosonic-Triggered Transferrin Receptor Clustering | 0.719 | neurodegeneration | Blood-brain barrier transport mechanisms |
| Transferrin-Alectinib Conjugation Enhances Blood-Brain Barri | 0.406 | molecular biology | Does Alectinib truly bind C1q directly w |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Autophagy receptor identification for stress granule elimination | exploratory | neurodegenerative diseases | 0.900 | 0.00 | cultured cells under arsenite | proposed | N/A |
| iPSC-derived endothelial cell iron uptake with RLS CSF exposure | exploratory | restless legs syndrome | 0.900 | 0.00 | iPSC-derived human endothelial | proposed | N/A |
| s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engin | falsification | Neuroinflammation | 0.400 | 0.50 | mouse | proposed | $200,000 |
| s:** - Compare uptake with/without magnetic particles using tight junc | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $120,000 |
| AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy | validation | Parkinson's Disease | 0.400 | 0.50 | mouse | proposed | $280,000 |
| AAV Serotype Comparison for LRRK2 Knockdown in PD | validation | Parkinson's Disease | 0.400 | 0.50 | mouse | proposed | $280,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] | Sehlin D, Hultqvist G, Michno W, Aguilar | J Prev Alzheimers Dis | 2025 | 1 |
| Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] | Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z | Exp Neurol | 2023 | 1 |
| On Iron Metabolism and Its Regulation. [PMID:33925597] | Vogt AS, Arsiwala T, Mohsen M, Vogel M, | Int J Mol Sci | 2021 | 1 |
| Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] | Feng H, Schorpp K, Jin J, Yozwiak CE, Ho | Cell Rep | 2020 | 1 |
| Transferrin and transferrin receptors update. [PMID:29969719] | Kawabata H | Free Radic Biol Med | 2019 | 1 |
| Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] | Lu Y, Zhang Y, Niu C | Comp Biochem Physiol A Mol Int | 2026 | 0 |
| Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] | Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam | J Trace Elem Med Biol | 2026 | 0 |
| Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] | Piotrowsky A, Leischner C, Schmieder H, | Oncol Rep | 2026 | 0 |
| Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] | Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng | American journal of translatio | 2026 | 0 |
| Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] | Zemmouche M, Falque G, Cadet F, Gardebie | Journal of molecular graphics | 2026 | 0 |
| [Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-r [PMID:41839581] | Wang YF, Dong YS | Zhen ci yan jiu = Acupuncture | 2026 | 0 |
| The therapeutic potential of Piezo1 channel-mediated ferroptosis and its inhibit [PMID:41854751] | Nan K, Zhang L, Zhao Y, Yin S, Peng Y, H | Apoptosis : an international j | 2026 | 0 |
| The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A [PMID:41833023] | Osmanlioglu Dag SR, Tatli Cankaya II, Oz | Anti-cancer agents in medicina | 2026 | 0 |
| Raccoon eyes [PMID:35789012] | Ning Junjie | Journal of Paediatrics and Chi | 2023 | 0 |
| The Trend of Immunotherapy Combined with Nanomedicine. [PMID:34789123] | Shigao Huang; Qi Zhao | Current medicinal chemistry | 2022 | 0 |
| Test-retest reliability for performance-based outcome measures among individuals [PMID:35123456] | ["Sions J", "Donohoe M", "Beisheim-Ryan | BMC musculoskeletal disorders | 2022 | 0 |
| Interfacial Imide Polymerization of Functionalized Filled Microcapsule Templates [PMID:36234567] | ["Wei Z", "Ma X", "Wang P", "Pan J"] | Nanomaterials (Basel, Switzerl | 2022 | 0 |
| The impact of COVID-19 and non-pharmaceutical interventions on energy returns wo [PMID:36567890] | ["Saif-Alyousfi A", "Saha A"] | Sustainable cities and society | 2021 | 0 |
| Implications of relationships with family, friends, and neighbors for changes in [PMID:33245678] | ["Fuller H"] | Journal of women & aging | 2021 | 0 |
| [Longitudinal Direct Closure of Mitral Anterior Leaflet Large Perforation for In [PMID:34876543] | Morizumi S, Enomoto Y, Ikeda K, Suzuki Y | Kyobu geka. The Japanese journ | 2021 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TRANSFERRIN in their description or question text
No additional research found